LiDCO Group Plc

Equities

LID

GB0030546849

Advanced Medical Equipment & Technology

Delayed London S.E. Other stock markets 11:35:19 2021-01-08 am EST			5-day change	1st Jan Change
11.75 ^GBX	-.--%		-.--%	-.--%

2020	Masimo Corporation completed the acquisition of LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others.	CI
2020	LiDCO : Takeover Offer by Masimo Declared Unconditional, Acceptances Exceed 90%	MT

LiDCO Group Plc Provides Sales Guidance for the Second Half of Financial Year Ending January 31, 2021

October 13, 2020 at 02:00 am EDT

LiDCO Group Plc provides sales guidance for the second half of financial year ending January 31, 2021. The Board anticipates that total sales in the second half will be broadly in line with in the second half of last year.

Latest news about LiDCO Group Plc

Masimo Corporation completed the acquisition of LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others.	20-12-30	CI
LiDCO : Takeover Offer by Masimo Declared Unconditional, Acceptances Exceed 90%	20-12-08	MT
LiDCO : Masimo's Takeover Offer for LiDCO Extended for Two Weeks as Acceptances Reach 75%	20-11-24	MT
LiDCO : Surges 68% on Acquisition by Masimo in $40 Million Deal	20-11-02	MT
Masimo Corporation reached agreement on the terms of a recommended cash offer to acquire LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others for £30.4 million.	20-11-01	CI
LiDCO Group Plc Provides Sales Guidance for the Second Half of Financial Year Ending January 31, 2021	20-10-13	CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2020	20-10-13	CI
LiDCO Group Plc Provides Sales Guidance for the Three Months Ending 30 April 2020	20-04-21	CI
Lidco Group plc Reports Earnings Results for the Full Year Ended January 31, 2020	20-04-21	CI
LiDCO Group plc Reports Revenues Results for the Full Year Ended 31 January 2020	20-02-13	CI
LiDCO Group Plc Announces LiDCOrapidv3 Launched in China	19-11-05	CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2019	19-10-15	CI
LiDCO Signs Variation Agreement to Existing Commercial Collaboration with Cnsystems Medizintechnik AG	19-09-12	CI
LiDCO Group plc Appoints James G. Wetrich to the Board, as A Non-Executive Director	19-08-15	CI
LiDCO Announces Latest Cardiac Output Monitor with Non-Invasive Technology Has Received Regulatory Approval for Commercial Sale in China	19-07-16	CI
LiDCO Group Plc Announces Revenue Results for the First Quarter Ended April 30, 2019	19-05-16	CI
LiDCO Group Plc Announces Regulatory Approval in South Korea	19-04-17	CI
LiDCO Group plc Announces Audited Consolidated Earnings Results for the Full Year Ended January 31, 2019; Provides Revenue Guidance for the Full Year of Fiscal 2019/2020	19-03-26	CI
LiDCO Group plc Wins 5 Year Contract	19-03-08	CI
LiDCO Group plc Announces Executive Changes	19-03-05	CI
LiDCO Group plc Reports Revenue Results for the Year Ended January 31, 2019	19-02-20	CI
LiDCO Group plc Provides Earnings Guidance for the Full Year Ending 31 January 2019	18-12-17	CI
LiDCO Group plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended July 31, 2018	18-10-09	CI
LiDCO Group plc Announces UK Distribution Agreement with Shenzhen Shenzhen Antmed Co.,Ltd	18-10-09	CI
Jill McGregor, Chief Financial Officer to Leave LiDCO Group plc	18-09-24	CI

Chart LiDCO Group Plc

Duration

Period

More charts

Company Profile

Lidco Group Ltd, formerly LiDCO Group Plc, is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Monitoring Systems

	1st Jan change	Capi.
LIDCO GROUP PLC	-.--%	40.52M
IRHYTHM TECHNOLOGIES, INC.	+4.55%	3.48B
EKF DIAGNOSTICS HOLDINGS PLC	-12.80%	156M
MEDIANA CO.,LTD	-15.69%	81.85M
NEUROTECH INTERNATIONAL LIMITED	+30.43%	59.71M

Medical Monitoring Systems